Reviews Bupropion Hydrochloride Extended-Release Tablets


No reviews yet.

Budeprion XL Drug Description
BUDEPRION XL™
(bupropion hydrochloride) Extended-Release Tablets USP (XL)

Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of BUDEPRION XL™ [bupropion hydrochloride
extended-release tablets (XL)] or any other antidepressant in a child, adolescent,
or young adult must balance this risk with the clinical need. Short-term studies
did not show an increase in the risk of suicidality with antidepressants compared
to placebo in adults beyond age 24; there was a reduction in risk with antidepressants
compared to placebo in adults aged 65 and older. Depression and certain other
psychiatric disorders are themselves associated with increases in the risk
of suicide. Patients of all ages who are started on antidepressant therapy
should be monitored appropriately and observed closely for clinical worsening,
suicidality, or unusual changes in behavior. Families and caregivers should
be advised of the need for close observation and communication with the prescriber.
BUDEPRION XL™ is not approved for use in pediatric patients. (See WARNINGS,
Clinical Worsening and Suicide Risk, PRECAUTIONS: INFORMATION
FOR PATIENTS, and PRECAUTIONS, Pediatric Use.)

DRUG DESCRIPTION



What are the possible side effects of bupropion?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any new or worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Call your doctor at once if...
Read All Potential Side Effects for Budeprion XL »




BUDEPRION XL™, an antidepressant of the aminoketone class, is chemically
unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor,
or other known antidepressant agents. Its structure closely resembles that of
diethylpropion; it is related to phenylethylamines.
It is designated as (±)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone
hydrochloride. The molecular weight is 276.2. The molecular formula is C13H18ClNO•HCl.
Bupropion hydrochloride powder is white, crystalline, and highly soluble in
water. It has a bitter taste and produces the sensation of local anesthesia
on the oral mucosa. The structural formula is:








BUDEPRION XL™ is supplied for oral administration as 150 mg, round white
to off-white extended-release tablets. Each tablet contains the labeled amount
of bupropion hydrochloride and the inactive ingredients: ethyl alcohol, ethylcellulose,
hydrochloric acid, hydroxypropylcellulose, methacrylic acid copolymer, povidone,
silicon dioxide, and hydrogenated vegetable oil. The tablets are printed with
edible black ink. The insoluble shell of the extended-release tablet may remain
intact during gastrointestinal transit and is eliminated in the feces. USP drug
release testing is pending.Last reviewed on RxList: 8/8/2008




Budeprion XL Drug Description
BUDEPRION XL™
(bupropion hydrochloride) Extended-Release Tablets USP (XL)

Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of BUDEPRION XL™ [bupropion hydrochloride
extended-release tablets (XL)] or any other antidepressant in a child, adolescent,
or young adult must balance this risk with the clinical need. Short-term studies
did not show an increase in the risk of suicidality with antidepressants compared
to placebo in adults beyond age 24; there was a reduction in risk with antidepressants
compared to placebo in adults aged 65 and older. Depression and certain other
psychiatric disorders are themselves associated with increases in the risk
of suicide. Patients of all ages who are started on antidepressant therapy
should be monitored appropriately and observed closely for clinical worsening,
suicidality, or unusual changes in behavior. Families and caregivers should
be advised of the need for close observation and communication with the prescriber.
BUDEPRION XL™ is not approved for use in pediatric patients. (See WARNINGS,
Clinical Worsening and Suicide Risk, PRECAUTIONS: INFORMATION
FOR PATIENTS, and PRECAUTIONS, Pediatric Use.)

DRUG DESCRIPTION



What are the possible side effects of bupropion?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any new or worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Call your doctor at once if...
Read All Potential Side Effects for Budeprion XL »




BUDEPRION XL™, an antidepressant of the aminoketone class, is chemically
unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor,
or other known antidepressant agents. Its structure closely resembles that of
diethylpropion; it is related to phenylethylamines.
It is designated as (±)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone
hydrochloride. The molecular weight is 276.2. The molecular formula is C13H18ClNO•HCl.
Bupropion hydrochloride powder is white, crystalline, and highly soluble in
water. It has a bitter taste and produces the sensation of local anesthesia
on the oral mucosa. The structural formula is:








BUDEPRION XL™ is supplied for oral administration as 150 mg, round white
to off-white extended-release tablets. Each tablet contains the labeled amount
of bupropion hydrochloride and the inactive ingredients: ethyl alcohol, ethylcellulose,
hydrochloric acid, hydroxypropylcellulose, methacrylic acid copolymer, povidone,
silicon dioxide, and hydrogenated vegetable oil. The tablets are printed with
edible black ink. The insoluble shell of the extended-release tablet may remain
intact during gastrointestinal transit and is eliminated in the feces. USP drug
release testing is pending.Last reviewed on RxList: 8/8/2008




Budeprion XL Drug Description
BUDEPRION XL™
(bupropion hydrochloride) Extended-Release Tablets USP (XL)

Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of BUDEPRION XL™ [bupropion hydrochloride
extended-release tablets (XL)] or any other antidepressant in a child, adolescent,
or young adult must balance this risk with the clinical need. Short-term studies
did not show an increase in the risk of suicidality with antidepressants compared
to placebo in adults beyond age 24; there was a reduction in risk with antidepressants
compared to placebo in adults aged 65 and older. Depression and certain other
psychiatric disorders are themselves associated with increases in the risk
of suicide. Patients of all ages who are started on antidepressant therapy
should be monitored appropriately and observed closely for clinical worsening,
suicidality, or unusual changes in behavior. Families and caregivers should
be advised of the need for close observation and communication with the prescriber.
BUDEPRION XL™ is not approved for use in pediatric patients. (See WARNINGS,
Clinical Worsening and Suicide Risk, PRECAUTIONS: INFORMATION
FOR PATIENTS, and PRECAUTIONS, Pediatric Use.)

DRUG DESCRIPTION



What are the possible side effects of bupropion?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any new or worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Call your doctor at once if...
Read All Potential Side Effects for Budeprion XL »




BUDEPRION XL™, an antidepressant of the aminoketone class, is chemically
unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor,
or other known antidepressant agents. Its structure closely resembles that of
diethylpropion; it is related to phenylethylamines.
It is designated as (±)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone
hydrochloride. The molecular weight is 276.2. The molecular formula is C13H18ClNO•HCl.
Bupropion hydrochloride powder is white, crystalline, and highly soluble in
water. It has a bitter taste and produces the sensation of local anesthesia
on the oral mucosa. The structural formula is:








BUDEPRION XL™ is supplied for oral administration as 150 mg, round white
to off-white extended-release tablets. Each tablet contains the labeled amount
of bupropion hydrochloride and the inactive ingredients: ethyl alcohol, ethylcellulose,
hydrochloric acid, hydroxypropylcellulose, methacrylic acid copolymer, povidone,
silicon dioxide, and hydrogenated vegetable oil. The tablets are printed with
edible black ink. The insoluble shell of the extended-release tablet may remain
intact during gastrointestinal transit and is eliminated in the feces. USP drug
release testing is pending.Last reviewed on RxList: 8/8/2008




Budeprion XL Drug Description
BUDEPRION XL™
(bupropion hydrochloride) Extended-Release Tablets USP (XL)

Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of BUDEPRION XL™ [bupropion hydrochloride
extended-release tablets (XL)] or any other antidepressant in a child, adolescent,
or young adult must balance this risk with the clinical need. Short-term studies
did not show an increase in the risk of suicidality with antidepressants compared
to placebo in adults beyond age 24; there was a reduction in risk with antidepressants
compared to placebo in adults aged 65 and older. Depression and certain other
psychiatric disorders are themselves associated with increases in the risk
of suicide. Patients of all ages who are started on antidepressant therapy
should be monitored appropriately and observed closely for clinical worsening,
suicidality, or unusual changes in behavior. Families and caregivers should
be advised of the need for close observation and communication with the prescriber.
BUDEPRION XL™ is not approved for use in pediatric patients. (See WARNINGS,
Clinical Worsening and Suicide Risk, PRECAUTIONS: INFORMATION
FOR PATIENTS, and PRECAUTIONS, Pediatric Use.)

DRUG DESCRIPTION



What are the possible side effects of bupropion?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any new or worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Call your doctor at once if...
Read All Potential Side Effects for Budeprion XL »




BUDEPRION XL™, an antidepressant of the aminoketone class, is chemically
unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor,
or other known antidepressant agents. Its structure closely resembles that of
diethylpropion; it is related to phenylethylamines.
It is designated as (±)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone
hydrochloride. The molecular weight is 276.2. The molecular formula is C13H18ClNO•HCl.
Bupropion hydrochloride powder is white, crystalline, and highly soluble in
water. It has a bitter taste and produces the sensation of local anesthesia
on the oral mucosa. The structural formula is:








BUDEPRION XL™ is supplied for oral administration as 150 mg, round white
to off-white extended-release tablets. Each tablet contains the labeled amount
of bupropion hydrochloride and the inactive ingredients: ethyl alcohol, ethylcellulose,
hydrochloric acid, hydroxypropylcellulose, methacrylic acid copolymer, povidone,
silicon dioxide, and hydrogenated vegetable oil. The tablets are printed with
edible black ink. The insoluble shell of the extended-release tablet may remain
intact during gastrointestinal transit and is eliminated in the feces. USP drug
release testing is pending.Last reviewed on RxList: 8/8/2008




Budeprion XL Drug Description
BUDEPRION XL™
(bupropion hydrochloride) Extended-Release Tablets USP (XL)

Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking
and behavior (suicidality) in children, adolescents, and young adults in short-term
studies of major depressive disorder (MDD) and other psychiatric disorders.
Anyone considering the use of BUDEPRION XL™ [bupropion hydrochloride
extended-release tablets (XL)] or any other antidepressant in a child, adolescent,
or young adult must balance this risk with the clinical need. Short-term studies
did not show an increase in the risk of suicidality with antidepressants compared
to placebo in adults beyond age 24; there was a reduction in risk with antidepressants
compared to placebo in adults aged 65 and older. Depression and certain other
psychiatric disorders are themselves associated with increases in the risk
of suicide. Patients of all ages who are started on antidepressant therapy
should be monitored appropriately and observed closely for clinical worsening,
suicidality, or unusual changes in behavior. Families and caregivers should
be advised of the need for close observation and communication with the prescriber.
BUDEPRION XL™ is not approved for use in pediatric patients. (See WARNINGS,
Clinical Worsening and Suicide Risk, PRECAUTIONS: INFORMATION
FOR PATIENTS, and PRECAUTIONS, Pediatric Use.)

DRUG DESCRIPTION



What are the possible side effects of bupropion?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any new or worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.
Call your doctor at once if...
Read All Potential Side Effects for Budeprion XL »




BUDEPRION XL™, an antidepressant of the aminoketone class, is chemically
unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor,
or other known antidepressant agents. Its structure closely resembles that of
diethylpropion; it is related to phenylethylamines.
It is designated as (±)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone
hydrochloride. The molecular weight is 276.2. The molecular formula is C13H18ClNO•HCl.
Bupropion hydrochloride powder is white, crystalline, and highly soluble in
water. It has a bitter taste and produces the sensation of local anesthesia
on the oral mucosa. The structural formula is:








BUDEPRION XL™ is supplied for oral administration as 150 mg, round white
to off-white extended-release tablets. Each tablet contains the labeled amount
of bupropion hydrochloride and the inactive ingredients: ethyl alcohol, ethylcellulose,
hydrochloric acid, hydroxypropylcellulose, methacrylic acid copolymer, povidone,
silicon dioxide, and hydrogenated vegetable oil. The tablets are printed with
edible black ink. The insoluble shell of the extended-release tablet may remain
intact during gastrointestinal transit and is eliminated in the feces. USP drug
release testing is pending.Last reviewed on RxList: 8/8/2008





Other reviews about Bupropion Hydrochloride Extended-Release Tablets on wordpress

Anchen files ANDA for Wellbutrin XL (buproprion)
  by mais
Anchen files ANDA for Wellbutrin XL (buproprion) Anchen files ANDA for Wellbutrin XL (buproprion) By Lawrence B. Ebert Taiwan-based generic company Anchen Pharmaceuticals has submitted an abbreviated new drug application (ANDA) […]


Federal Agency Approves Use Of Generic Wellbutrin In Depression Patients
  by nitish
The U.S. Food and Drug Administration said Wednesday that a generic version of a popular name brand antidepressant is both safe and effective, despite recent consumer complaintsThe federal […]


GlaxoSmithKline - Products
  by El Horror
About - Every second: Distributes more than 35 doses of vaccine. - Every minute: More than 1,100 prescriptions are written for GSK products. - Every hour: Spends more than $562,000 to […]


Sun Pharma gets US nod for anti-depressant
  by INDOLINK Consulting (es)
The US-based subsidiary of the company has received Food and Drug Administration approval to market its drug Bupropion Hydrochloride Bupropion Hydrochloride Extended-Release, Sun Pharmaceutical said in a filing […]


Caraco Markets Generic Wellbutrin
  by mnroush
Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) said Wednesday that it had started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the United States […]


And then, in the mans
  by azttiwuenarpjon


You got some money for us, Ray sa
  by cciyfnpcubzwq
If, however, the tip catches a minute projecting point, the other branches form discs, especially if they find crevices to crawl into. We thought hed like to know […]


So Dorothy sat on the hearthshelf of
  by ikdrqkscrfcy
Mysteries hedged him on all sides, warnings ran before his heavy feet, and countersigns were muttered behind his attentive back. Ill think of it, but mind you, Mac, […]


Dont vanish before I get back.
  by dwzgrhwnnrwrxkn
Today Mary Standish was ahead of him at the table. Standing at the edge of the trench, they realized that they had never both gone down together. Well, […]


and once they got going again, the wo
  by wggdjipidegtz
It was my love to this book only that made me to venture into this adventure. If the first shots had no decisive effect, they were to fire […]



Other reviews about Bupropion Hydrochloride Extended-Release Tablets on web:

Learn about the prescription medication Budeprion XL (Bupropion Hydrochloride Extended-Release Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and ... Budeprion XL (Bupropion Hydrochloride Extended-Release Tablets ...


PRESCRIBING INFORMATION WELLBUTRIN XL ® (bupropion hydrochloride extended-release tablets) Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to ... WELLBUTRIN XL® (bupropion hydrochloride extended-release tablets)


Wellbutrin XL Drug Description. WELLBUTRIN XL® (bupropion hydrochloride) Extended-Release Tablets . WARNING . Suicidality and Antidepressant Drugs . Use in Treating ... Wellbutrin XL (Bupropion Hydrochloride Extended-Release) Drug ...


Psychiatric Times is the most widely read publication in the field of psychiatry. The Web site features outstanding columnists, compelling features, vital clinical news, intriguing ... Bupropion Hydrochloride Tablet, Extended Release - Psychiatric Times


1 PRESCRIBING INFORMATION WELLBUTRIN XL ™ (bupropion hydrochloride extended-release tablets) "Patient Information" enclosed. DESCRIPTION WELLBUTRIN XL (bupropion ... wellbutrin xl extended-release tablets


When switching from bupropion hydrochloride ( Wellbutrin immediate-release, SR, and XL ... Aplenzin Extended-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer) Complete Bupropion Hydrochloride information from Drugs.com


BUPROPION HYDROCHLORIDE EXTENDED RELEASE TABLETS (Wellbutrin XL ) Classification: Aminoketone antidepressant . Indication: Treatment of major depressive disorder BUPROPION HYDROCHLORIDE EXTENDED RELEASE TABLETS


Psychiatric Times is the most widely read publication in the field of psychiatry. The Web site features outstanding columnists, compelling features, vital clinical news, intriguing ... Bupropion Hydrochloride Extended-Release Tablet, Film Coated ...


Bupropion Hydrochloride Extended-Release Tablets USP (XL) Bupropion Hydrochloride Extended-Release Tablets USP (XL) PRESCRIBING INFORMATION Bupropion hydrochloride extended-release tablets ... bupropion hydrochloride extended-release (er) tablets usp (xl)


Incidence in Controlled Trials with Bupropion Hydrochloride Extended-Release Tablets (SR) Adverse Events Associated with Discontinuation of Treatment Among Patients Treated with ... Bupropion Side Effects | Drugs.com





Featured Reviews

Reviews Fluorescein

Fluorescite Drug Description FLUORESCITE® (fluorescein) Injection, USP 10% Sterile DRUG DESCRIPTION FLUORESCITE® (fluorescein injection, USP) 10% contains fluorescein sodium (equivalent to fluorescein 10% w/v). It is a sterile...
Read More  |  Review This
Reviews Salmeterol Xinafoate

Serevent Diskus Drug Description Serevent® Diskus® (salmeterol xinafoate) Inhalation Powder For Oral Inhalation Only WARNING Long-acting beta2-adrenergic agonists, such as salmeterol, the active ingredient in SEREVENT DISKUS,...
Read More  |  Review This
Reviews Luvox CR

Luvox CR Drug Description LUVOX® CR (fluvoxamine maleate) Extended-Release Capsules 100 mg and 150 mg Suicidally and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior...
Read More  |  Review This
Reviews Valsartan and Hydrochlorothiazide

Diovan HCT Drug Description Diovan HCT (valsartan and hydrochlorothiazide USP) Tablets WARNING AVOID USE IN PREGNANCY When pregnancy is detected, discontinue Diovan HCT® as soon as possible. Drugs that act directly on the renin-angiotensin...
Read More  |  Review This
Reviews Hexalen

Hexalen Drug Description HEXALEN® (altretamine) Capsules 50 mg WARNINGS HEXALEN® capsules should only be given under the supervision of a physician experienced in the use of antineoplastic agents. Peripheral...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....